Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Parkinson's Disease Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.The report estimates...
-
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis Market (2024 Edition): Size, Trends, Opportunities and Forecast by Treatment Type, Drug, Distribution Channel, and...
-
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Multiple...
-
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The chemotherapy...
-
Dublin, May 26, 2021 (GLOBE NEWSWIRE) -- The "Gene and Cell Therapies Targeting CNS Disorders - Market Insights and Market Forecast - 2026" report has been added to ResearchAndMarkets.com's...
-
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Parkinson's Disease - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The global PD...
-
DOYLESTOWN, Pa., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced today...
-
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis Market Insight, Epidemiology and Market Forecast -2030" drug pipelines has been added to ResearchAndMarkets.com's...